Serum antibodies to HIV-1 are produced post-measles virus infection: Evidence for cross-reactivity with HLA

Clinical and Experimental Immunology

Volumn 111, Issue 2, 1998, Pages 251-256

  Baskar, P V ^a   Collins, G D ^a   Dorsey Cooper, B A ^a   Pyle, R S ^a   Nagel, J E ^a   Dwyer, D ^b   Dunston, G ^c   Johnson, C E ^d   Kendig, N ^a   Israel, E ^b   Nalin, D R ^e   Adler, W H ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Maryland State Health Department   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

HIV 1; Indeterminate Western blot; Measles

Indexed keywords

ANTIGEN P24; AUTOANTIGEN; CROSS REACTING ANTIBODY; GAG PROTEIN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; POL PROTEIN; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CONVALESCENCE; CROSS REACTION; HLA TYPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MEASLES; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL;

ABSORPTION; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CROSS REACTIONS; EPITOPES; GENE PRODUCTS, GAG; HIV ANTIBODIES; HIV-1; HLA ANTIGENS; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; MEASLES;

EID: 6844258879     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00488.x     Document Type: Article

References (42)

1. Golding H, Shearer GM, Hillman K et al. Common epitope in human immunodeficiency virus (HIV) I-gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV-1-infected individuals. J Clin Invest 1989; 83:1430-5.
2. Kion TA, Hoffman GW. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 1991; 253:1138-40.
3. Chicz RM, Urban RG, Lane WS, Gorga JC, Ster MLJ, Vignali DA, Strominger JML. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992; 358: 764-8.
4. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JML. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27-47.
5. Golding H, Robe FA, Gates FT III, Linder W, Beining PR, Hoffman T, Golding B. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class IIβ 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med 1988; 167:914-23.
6. Habeshaw JA, Dalgleish AG, Bountiff ML, Newell AML, Wilks D, Walker MLC, Manca F. AIDS pathogenesis: HIV envelope and its interaction with cell proteins. Immunol Today 1990; 11:418-24.
7. Morrow WJ, Isenberg DA, Sobol RE, Stricke RB, Kieber-Emmons T. AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol 1991; 58:163-80.
8. Schattner A, Bentwich Z. Autoimmunity in human immunodeficiency virus infection. Clin Aspects Autoimmun 1993; 5:19-27.
9. Ilonen J, Mäkelä MJ, Ziola B, Salmi AA. Cloning of human T cells specific for measles virus haemagglutinin and nucleocapsid. Clin Exp Immunol 1990; 81:212-7.
10. Fujinami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985; 230:1043-6.
11. Sette A, Buus S, Appella E, Smith JA, Chesnut R, Miles C, Colon SM, Grey HM. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci USA 1989; 86:3296-300.
12. β sequences. Science 1991; 254:860-2.
13. f system I. A novel "polymorphism" of endogenous superantigens. J Immunol 1992; 149:3429-39.
14. f-reactive T cells. J Immunol 1992; 149:3440-7.
15. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D. Evidence for a viral superantigen in humans. Nature 1992; 358:507-10.
16. Dalgleish AG, Wilson S, Gompels M, Ludlam C, Gazzard B, Coates AM, Habershaw J. T-cell receptor variable gene products and early HIV-1 infection. Lancet 1992; 339:824-8.
17. Ura Y, Hara T, Nagata M, Mizuno Y, Ueda K, Matsuo M, Mori Y, Miyazaki S. T cell activation and T cell receptor variable region gene usage in measles. Acta Paediatr Jpn 1992; 34:273-7.
18. Midthun K, Garrison L, Clements ML, Farzadegan H, Fernie B, Quinn T. AIDS Vaccine Trials Network. Frequency of indeterminate Western blot tests in healthy adults at low risk for human immunodeficiency virus infection. J Infect Dis 1990; 162:1379-82.
19. Burke DS, Redfield RR, Putman P, Alexander SS. Variations in western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. J Clin Microbiol 1987; 25:81-84.
20. Biggar RJ, Gigase PL, Melbye M et al. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet 1985; 2:520-3.
21. Biggar RJ, Saxinger C, Sarin P, Blattner WA. Non-specificity of HTLV III reactivity in sera from rural Kenya and eastern Zaire. East Afr Med J 1986; 63:683-4.
22. Parry JV, Richmond J, Edwards N, Noone A. Spurious malarial antibodies in HIV infection. Lancet 1992; 340:1413-4.
23. Christie IL, Palmer SJ, Voller A, Banatvala JE. False-positive serology and HIV infection. Lancet 1993; 341:441-2.
24. Jehuda-Cohen T, Slade BA, Powell JD et al. Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1 seronegative individuals. Proc Natl Acad Sci USA 1990; 87:3972-6.
25. Sherman MP, Dock NL, Ehrlich GD, Sninsky JJ, Brothers C, Gillsdorf J, Bryz-Gornia V, Poiesz BJ. Evaluation of HIV type 1 Western blot-indeterminate blood donors for the presence of human or bovine retroviruses. AIDS Res Hum Retroviruses 1995; 11:409-14.
26. Esolen LM, Ward BJ, Moench TR, Griffin DE. Infection of monocytes during measles. J Infect Dis 1993; 168:47-52.
27. Yamanouchi K, Egashira Y, Uchida N, Kodoma H, Kobune F, Hayami M, Fukuda A, Shishido A. Giant cell formation in lymphoid tissues of monkeys inoculated with various strains of measles virus. Jpn J Med Sci Biol 1970; 23:131-45.
28. Yamanouchi K, Chino F, Kobune F, Kodama H, Tsuruhara T. Growth of measles virus in the lymphoid tissues of monkeys. J Infect Dis 1973; 128:795-9.
29. Osunkoya BO, Adeleye GI, Adejumo TA, Salimonu LS. Studies on leukocyte cultures in measles. II. Detection of measles virus antigen in human leucocytes by immunofluorescence. Arch Gesamte Virusforsch 1974; 44:323-9.
30. + T-cell subset. In: Bishop DHL, Compans RW, eds. Nonsegmented negative strand viruses: paramyxoviruses and rhabdoviruses. New York: Academic Press, 1984:435-42.
31. Forthal DN, Aarnaes S, Blanding J, de la Maza L, Tilles JG. Degree and length of viremia in adults with measles. J Infect Dis 1992; 166: 421-4.
32. Sha BE, Harris AA, Benson CA et al. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis 1991; 164:973-5.
33. McChesney MB, Oldstone MB. Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. Adv Immunol 1989; 45: 335-80.
34. Spear GT, Ou CY, Kessler HA, Landay AL. Analysis of lymphocytes, monocytes and neutrophils from human immunodeficiency virus (HIV)-infected persons for HIV DNA. J Infect Dis 1990; 162:1239-44.
35. Ihara T, Yasuda N, Kitamura K, Ochiai H, Kamiya H, Sakurai M. Prolonged viremic phase in children with measles (letter). J Infect Dis 1992; 166:941.
36. Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis 1993; 168:275-81.
37. Segal BM, Klinman DM, Shevach EM. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J Immunol 1997; 158:5087-90.
38. Arthur LO, Bess JW Jr, Sowder RC II, Benveniste RE, Mann DL, Chermann JC, Henderson LE. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992; 258:1935-8.
39. Orentas RJ, Hildreth JEK. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses 1993; 9:1157-65.
40. Morrow WJW, Isenberg DA, Sobol RE, Stricker RB, Kieber-Emmons T. AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol 1991; 58:163-80.
41. Drabick JJ, Baker JR Jr. HLA antigen contamination of commercial Western blot strips for detecting human immunodeficiency virus. J Infect Dis 1989; 159:357-8.
42. Andrieu JM, Even P, Venet A et al. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin Immunol Immunopathol 1988; 47:181-98.